From: Prognostic analysis for Chinese patients with stage I ovarian endometrioid carcinoma
Variable | β | P | HR(95% CI) |
---|---|---|---|
Menopause | 0.33464 | 0.6072 | 1.4 (0.39 ~ 5.01) |
Stage | 0.15452 | 0.856 | 1.17 (0.22 ~ 6.2) |
Grade2–1 | 0.58496 | 0.4369 | 1.8 (0.41 ~ 7.84) |
Grade3–1 | 1.58441 | 0.0259* | 4.88 (1.21 ~ 19.66) |
Lymphadenectomy | −1.737 | 0.0276* | 0.18 (0.04 ~ 0.83) |
Cytology of ascites | 0.55961 | 0.4701 | 1.75 (0.38 ~ 7.99) |
Chemotherapy cycle | 1.32926 | 0.0598 | 3.78 (0.95 ~ 15.08) |